| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
72,540,000 |
| Market
Cap: |
639.08(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.26 - $9.68 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 7.1 |
| Insider 3/6 Months : 7.7 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile KemPharm is a specialty pharmaceutical company focused on the discovery and development of treatments for central nervous system (CNS) and rare disease indications that allow it to target areas with unmet needs. Co.'s prodrug product candidate pipeline is focused on the idiopathic hypersomnia (IH) and other CNS/rare diseases. Co.'s approved product, AZSTARYS®, a once-daily treatment for attention deficit hyperactivity disorder in patients, age six years and older, contains its prodrug, serdexmethylphenidate (SDX). Co.'s primary clinical development product candidate, KP1077, is based on SDX, its prodrug of d-methlyphenidate and is in development for the treatment of IH and narcolepsy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
10,300 |
32,800 |
54,300 |
| Total Buy Value |
$0 |
$81,976 |
$226,200 |
$333,821 |
| Total People Bought |
0 |
2 |
4 |
5 |
| Total Buy Transactions |
0 |
2 |
6 |
10 |
| Total Shares Sold |
0 |
116,317 |
116,317 |
116,317 |
| Total Sell Value |
$0 |
$919,976 |
$919,976 |
$919,976 |
| Total People Sold |
0 |
4 |
4 |
4 |
| Total Sell Transactions |
0 |
5 |
5 |
5 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Thompson Rahsaan |
Chief Legal & ComplianceSecret |
• • – |
2025-06-26 |
4 |
AS |
$9.21 |
$221,004 |
D/D |
(24,000) |
42,666 |
|
- |
|
| Thompson Rahsaan |
Chief Legal & ComplianceSecret |
• • – |
2025-06-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
66,666 |
66,666 |
|
- |
|
| Watton Corey Michael |
Director |
• • – |
2025-03-28 |
4 |
B |
$7.84 |
$2,352 |
D/D |
300 |
1,800 |
2.31 |
15% |
|
| Bode John B |
Director |
• • – |
2025-03-19 |
4 |
B |
$7.96 |
$79,624 |
D/D |
10,000 |
40,000 |
2.39 |
13% |
|
| Mcfarlane Neil F. |
President and CEO |
• • – |
2025-02-14 |
4 |
AS |
$8.05 |
$245,962 |
D/D |
(30,544) |
191,516 |
|
15% |
|
| Mcfarlane Neil F. |
President and CEO |
• • – |
2025-02-13 |
4 |
AS |
$7.86 |
$481,428 |
D/D |
(61,273) |
222,060 |
|
17% |
|
| Sangiovanni Timothy J. |
SVP, Finance & Corp Controller |
• • – |
2025-02-13 |
4 |
AS |
$7.86 |
$23,588 |
D/D |
(3,000) |
16,341 |
|
17% |
|
| Schafer Joshua |
CCO & EVP, Bus. Development |
• • – |
2025-02-13 |
4 |
AS |
$7.86 |
$82,527 |
D/D |
(10,500) |
29,486 |
|
17% |
|
| Clifton R. Laduane |
CFO & Treasurer |
• • – |
2025-02-13 |
4 |
AS |
$7.86 |
$86,471 |
D/D |
(11,000) |
51,361 |
|
17% |
|
| Schafer Joshua |
CCO & EVP, Bus. Development |
• • – |
2025-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,333 |
39,986 |
|
- |
|
| Mcfarlane Neil F. |
President and CEO |
• • – |
2025-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
233,333 |
283,333 |
|
- |
|
| Clifton R. Laduane |
CFO & Treasurer |
• • – |
2025-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
43,333 |
62,361 |
|
- |
|
| Sangiovanni Timothy J. |
SVP, Finance & Corp Controller |
• • – |
2025-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,666 |
19,341 |
|
- |
|
| Quartel Adrian W |
Chief Medical OfficerOfficer |
• – – |
2024-12-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,923 |
|
-25% |
|
| Watton Corey Michael |
Director |
• • – |
2024-10-11 |
4 |
B |
$7.92 |
$3,958 |
D/D |
500 |
1,500 |
2.31 |
-9% |
|
| Clifton R. Laduane |
CFO & Treasurer |
• • – |
2024-07-17 |
4 |
B |
$6.77 |
$13,540 |
D/D |
2,000 |
18,469 |
2.74 |
45% |
|
| Anderson Thomas |
Director |
• • – |
2024-07-16 |
4 |
B |
$6.81 |
$68,065 |
D/D |
10,000 |
20,000 |
2.39 |
40% |
|
| Bode John B |
Director |
• • – |
2024-07-12 |
4 |
B |
$5.87 |
$58,661 |
D/D |
10,000 |
30,000 |
2.39 |
53% |
|
| Anderson Thomas |
Director |
• • – |
2023-09-06 |
4 |
B |
$4.88 |
$48,764 |
D/D |
10,000 |
10,000 |
2.39 |
17% |
|
| Clifton R. Laduane |
CFO, Secretary & Treasurer |
• • – |
2023-09-06 |
4 |
B |
$4.96 |
$4,959 |
D/D |
1,000 |
15,309 |
2.66 |
17% |
|
| Schafer Joshua |
CCO & EVP, Bus. Development |
• • – |
2023-09-05 |
4 |
B |
$5.13 |
$2,565 |
D/D |
500 |
3,500 |
2.66 |
18% |
|
| Bode John B |
Director |
• • – |
2023-09-05 |
4 |
B |
$5.13 |
$51,333 |
D/D |
10,000 |
20,000 |
2.39 |
18% |
|
| Watton Corey Michael |
Director |
• • – |
2023-06-23 |
4 |
B |
$5.95 |
$1,636 |
D/D |
275 |
1,000 |
2.31 |
-19% |
|
| Watton Corey Michael |
Director |
• • – |
2023-06-09 |
4 |
B |
$5.52 |
$1,794 |
D/D |
325 |
725 |
2.31 |
-21% |
|
| Watton Corey Michael |
Director |
• • – |
2023-05-30 |
4 |
B |
$5.11 |
$2,042 |
D/D |
400 |
400 |
2.31 |
-7% |
|
151 Records found
|
|
Page 1 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.19 (2.11%) 
